Breaking News Instant updates and real-time market news.

DPZ

Domino's Pizza

$293.12

8.48 (2.98%)

, PZZA

Papa John's

$60.84

1.29 (2.17%)

05:55
12/12/19
12/12
05:55
12/12/19
05:55

Stephens to hold a plane trip

Restaurants Plane Trip will begin in Michigan and travel through Ann Arbor, Louisville and end in Memphis, TN on December 11-12.

DPZ

Domino's Pizza

$293.12

8.48 (2.98%)

PZZA

Papa John's

$60.84

1.29 (2.17%)

TXRH

Texas Roadhouse

$57.25

0.55 (0.97%)

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

DPZ Domino's Pizza
$293.12

8.48 (2.98%)

12/02/19
OPCO
12/02/19
NO CHANGE
Target $325
OPCO
Outperform
Domino's Pizza price target raised to $325 from $295 at Oppenheimer
Oppenheimer analyst Brian Bittner raised his price target for Domino's Pizza to $325 from $295, saying Domino's remains one of his top picks into 2020 despite stock's outperformance so far in Q4. The analyst tells investors in a research note that he believes relative valuation remains "attractive," and anticipates a new large share repurchase.
12/09/19
RBCM
12/09/19
INITIATION
Target $337
RBCM
Outperform
Domino's Pizza initiated with an Outperform at RBC Capital
RBC Capital analyst Christopher Carril initiated coverage of Domino's Pizza with an Outperform rating and $337 price target. The analyst is positive on the setup in the stock heading into easier comparisons and the likelyhood of less impact from 3rd party delivery competition. Carril further expects Domino's Pizza's "best-in-class" unit growth and more achievable same-store stales outlook supporting the stock's continued outperformance.
12/10/19
12/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Restaurant Brands (QSR), Domino's Pizza (DPZ), McDonald's (MCD), and Starbucks (SBUX) were initiated with Outperform ratings at RBC Capital, while Wendy's (WEN), Chipotle (CMG), Dunkin' Brands (DNKN), Brinker (EAT), Yum! Brands (YUM), and Texas Roadhouse (TXRH) were initiated with Sector Perform ratings. 2. Aravive (ARAV) initiated with an Overweight at Cantor Fitzgerald. 3. Borr Drilling (BORR) initiated with a Buy at Goldman Sachs. 4. Axon (AAXN) initiated with an Outperform at JMP Securities. 5. Zoom Video (ZM) initiated with a Neutral at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/19
NRCS
11/26/19
NO CHANGE
NRCS
Domino's Pizza checks show slowing momentum, says Northcoast
Northcoast analyst Jim Sanderson is more cautious on shares of Domino's Pizza after recent channel and digital marketing checks suggested the company's U.S. same-store-sales trends are losing momentum. He believes current trends must improve in order for Domino's to meet his Q4 same-store-sales estimate of up 2.1%. He reiterates a Neutral rating on the shares.
PZZA Papa John's
$60.84

1.29 (2.17%)

11/07/19
11/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from In Line at Evercore ISI with analyst Kevin Rippey citing his view that 2018 represented a period of "unsustainably high" margins as Twitter reaped the benefits of a period of sustained underinvestment. 2. Mylan (MYL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger sayinge has become more conservative in his estimates after competing U.S. generic businesses missed estimates in the past two days, which he thinks may be indicative of ongoing industry pressures. 3. Expedia (EXPE) downgraded to Neutral from Overweight at Piper Jaffray and to Neutral from Buy at DA Davidson and BofA/Merrill. 4. Bloomin' Brands (BLMN) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe citing valuation. 5. Papa John's (PZZA) downgraded to Neutral from Buy at MKM Partners with analyst Brett Levy saying the company has generated its first positive domestic comps in two years while laying the foundation for a "potential turnaround," but after a 43% run-up in the stock price since August 23, he believes the valuation warrants a neutral stance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/19
LBOW
11/22/19
NO CHANGE
Target $73
LBOW
Buy
Papa John's checks signal 'surprisingly' good sales for new pizza, says Longbow
Longbow analyst Alton Stump said his talks with Papa John's franchisees lead him to believe U.S. system-wide same-store sales are up 2.5%-3.0% in Q4 to-date, which he notes is tracking ahead of the consensus forecast for the full quarter. The analyst, who has been told by franchisees that the new Garlic Parmesan Crust has sold "surprisingly well" since its launch in in early November, believes further sequential acceleration in same-stores sales in Q4 would be viewed positively by investors. Stump keeps a Buy rating on Papa John's shares.
11/07/19
BTIG
11/07/19
NO CHANGE
Target $67
BTIG
Buy
Papa John's price target raised to $67 from $62 at BTIG
BTIG analyst Peter Saleh raised his price target on Papa John's to $67 and kept his Buy rating after its Q3 results, saying the quarter was one of its strongest in years. The analyst cites North America same-store sales moving to positive for the first time in two years along with the company's "significant expansion" in restaurant margins. Saleh adds that franchise economics remain under pressure, but he believes Q3 marked the "turning point" as sales turned positive and unit economics likely followed.
11/07/19
MKMP
11/07/19
DOWNGRADE
Target $60
MKMP
Neutral
Papa John's downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Brett Levy downgraded Papa John's to Neutral from Buy but raised his price target to $60, up from $55, following its in-line Q2 earnings and affirmed FY19 guidance. The analyst notes that the company has generated its first positive domestic comps in two years while laying the foundation for a "potential turnaround", but after a 43% run-up in the stock price since August 23rd, he believes the valuation warrants a neutral stance.
TXRH Texas Roadhouse
$57.25

0.55 (0.97%)

10/30/19
MAXM
10/30/19
DOWNGRADE
Target $60
MAXM
Hold
Texas Roadhouse downgraded to Hold from Buy at Maxim
Maxim analyst Stephen Anderson downgraded Texas Roadhouse to Hold from Buy with an unchanged price target of $60.
12/09/19
RBCM
12/09/19
INITIATION
Target $60
RBCM
Sector Perform
Texas Roadhouse initiated with a Sector Perform at RBC Capital
RBC Capital analyst Christopher Carril started coverage of Texas Roadhouse with a Sector Perform rating and $60 price target. Carril said that the company remains a "rarity" in casual dining, posting consistent positive traffic along with "near best-in-class" unit growth. The analyst noted that the stock is already trading at a premium to peers, adding that he sees risk from continued labor pressures and views consensus labor estimates for 2020 as possibly too optimistic.
12/12/19
GSCO
12/12/19
INITIATION
Target $52
GSCO
Sell
Texas Roadhouse initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Katherine Fogertey initiated coverage of Texas Roadhouse with a Sell rating and $52 price target. While the analyst expects the company to continue outperforming industry peers from a comp perspective, she's concerned that higher commodity and labor inflation in 2020 will drive restaurant margins below its longer term guidance of 17%-18%. Consensus estimates are not adequately modeling the impact to margins, Fogertey tells investors in a research note.

TODAY'S FREE FLY STORIES

SPOT

Spotify

$148.20

-3.59 (-2.37%)

18:15
01/17/20
01/17
18:15
01/17/20
18:15
Periodicals
Spotify in talks to acquire The Ringer, WSJ reports »

Spotify is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CE

Celanese

$117.54

-0.53 (-0.45%)

18:00
01/17/20
01/17
18:00
01/17/20
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BYND

Beyond Meat

$109.20

-1.16 (-1.05%)

17:58
01/17/20
01/17
17:58
01/17/20
17:58
Periodicals
Beyond Meat rival gets green light in Canada, The Star says »

Impossible Foods, a maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBD

Diebold

$11.09

-0.49 (-4.23%)

17:42
01/17/20
01/17
17:42
01/17/20
17:42
Periodicals
Breaking Periodicals news story on Diebold »

Diebold Nixdorf divests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

, SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SLV

iShares Silver Trust

$16.82

0.04 (0.24%)

GLD

SPDR Gold Shares

$146.59

0.29 (0.20%)

FXE

Euro Currency Trust

$105.10

-0.43 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSFY

Ubisoft

$0.00

(0.00%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
Periodicals
Ubisoft to restructure editorial team after difficult 2019, VGC reports »

Ubisoft intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Feb

IMVT

Immunovant

$17.04

-0.01 (-0.06%)

17:27
01/17/20
01/17
17:27
01/17/20
17:27
Syndicate
Breaking Syndicate news story on Immunovant »

Immunovant files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBLT

ToughBuilt

$0.33

-0.0255 (-7.11%)

17:20
01/17/20
01/17
17:20
01/17/20
17:20
Syndicate
ToughBuilt files to sell common stock, no amount given »

Maxim acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYO

Myomo

$0.32

0.0062 (1.98%)

17:18
01/17/20
01/17
17:18
01/17/20
17:18
Conference/Events
Myomo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRRA

Sierra Oncology

$0.40

-0.02 (-4.76%)

17:14
01/17/20
01/17
17:14
01/17/20
17:14
Conference/Events
Sierra Oncology to host virtual special shareholder meeting »

Virtual Special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRNE

Sorrento Therapeutics

$4.26

-0.15 (-3.40%)

17:10
01/17/20
01/17
17:10
01/17/20
17:10
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$3.45

-0.1 (-2.82%)

17:01
01/17/20
01/17
17:01
01/17/20
17:01
Hot Stocks
Akers Biosciences reaches settlement agreements on two derivative actions »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.09

-0.18 (-4.22%)

16:40
01/17/20
01/17
16:40
01/17/20
16:40
Hot Stocks
Encana receives court approval for reorganization »

Encana Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

MBRX

Moleculin Biotech

$0.96

0.0122 (1.29%)

16:38
01/17/20
01/17
16:38
01/17/20
16:38
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.07

-0.225 (-1.11%)

, BT

BT Group

$0.00

(0.00%)

16:37
01/17/20
01/17
16:37
01/17/20
16:37
Periodicals
BT, Vodafone consider urging PM Johnson not to ban Huawei in U.K., Reuters says »

BT Group (BT) and…

VOD

Vodafone

$20.07

-0.225 (-1.11%)

BT

BT Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/17/20
01/17
16:30
01/17/20
16:30
Options
Preliminary option volume of 28.7M today »

Preliminary option volume…

NSCO

Nesco Holdings

$5.12

0.025 (0.49%)

16:26
01/17/20
01/17
16:26
01/17/20
16:26
Syndicate
Nesco Holdings requests withdrawal of registration statement »

Nesco Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$18.54

-0.075 (-0.40%)

, CMCSA

Comcast

$47.48

0.62 (1.32%)

16:20
01/17/20
01/17
16:20
01/17/20
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

The major averages were…

GPS

Gap

$18.54

-0.075 (-0.40%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

CMCSK

Comcast

$0.00

(0.00%)

PLAY

Dave & Buster's

$47.35

5.3 (12.60%)

KKR

KKR

$31.20

0.7 (2.30%)

BA

Boeing

$324.11

-7.89 (-2.38%)

JNJ

Johnson & Johnson

$149.07

0.82 (0.55%)

SWK

Stanley Black & Decker

$172.63

2.18 (1.28%)

TWOU

2U

$22.84

1.05 (4.82%)

BE

Bloom Energy

$9.70

0.43 (4.64%)

MGPI

MGP Ingredients

$38.16

-14.74 (-27.86%)

FAST

Fastenal

$36.77

-0.55 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 20

    Jan

  • 22

    Jan

  • 23

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 26

    Feb

  • 27

    Feb

  • 09

    Mar

  • 17

    Mar

APLS

Apellis

$40.43

0.03 (0.07%)

16:18
01/17/20
01/17
16:18
01/17/20
16:18
Hot Stocks
Apellis CEO sells 30.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
01/17/20
01/17
16:17
01/17/20
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
01/17/20
01/17
16:16
01/17/20
16:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
01/17/20
01/17
16:15
01/17/20
16:15
General news
Treasury Market Summary »

Treasury Market Summary:…

LGC

Legacy Acquisition Corp

$10.33

(0.00%)

16:08
01/17/20
01/17
16:08
01/17/20
16:08
Hot Stocks
Legacy Acquisition Corp extends date to consummate proposed business combination »

Legacy Acquisition Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNUS

Genius Brands

$0.33

-0.015 (-4.41%)

16:04
01/17/20
01/17
16:04
01/17/20
16:04
Syndicate
Breaking Syndicate news story on Genius Brands »

Genius Brands files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$90.21

1.28 (1.44%)

16:04
01/17/20
01/17
16:04
01/17/20
16:04
Periodicals
Best Buy board opens investigation into CEO's personal conduct, WSJ says »

The board of Best Buy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.